This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Welcome back to the Cost Corner, where we provide practical insight into the complex cost and pricing requirements that apply to Government Contractors. We just completed two articles on the Truth in Negotiations Act (TINA) [1] and, before that, two articles on Defense Contract Audit Agency (DCAA) audits.
The lead story in this Wall Street Journal article makes me sick. Johnston best of luck in her next pricenegotiation with a “proven enterprise technology company.” In the article, Ms. I sincerely wish Ms. And I sure as hell hope they call her bluff. So, please, be genuine.
419 (2023), where he posited, “[t]here are substantial arguments that the qui tam device is inconsistent with Article II and that private relators may not represent the interests of the United States in litigation.” NW, Washington, D.C. 20006), but will be offered to both in-person and virtual attendees. Polansky v.
The shutdown could slow the implementation of the administration’s Medicare drug pricenegotiations (set to begin October 1, 2023), and could threaten HHS oversight of the Medicaid “unwinding” process, as states reevaluate the eligibility of enrollees. View the full article
This article breaks down the essential rules every contractor needs to know. The FAR covers various aspects, including contract formation, administration, pricing, and subcontracting standards, ensuring a standardized approach to federal procurement.
A future article in the Friday Flash will provide more details on the requirements in these DFARS clauses. The first group of negotiatedprices are for 10 Medicare Part D drugs that treat a variety of conditions including cardiovascular disease, diabetes, autoimmune diseases and cancer.
John Tenaglia , who is the Principal Director of Defense Pricing and Contracting in the Office of the Undersecretary of Defense, Acquisition & Sustainment (“ OUSD(A&S) ”), provided guidance to DoD contracting offices about using EPA clauses to remedy inflation. 95] The clause fixes each adjustment to the PPI. [96]
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content